The induction of type i interferon production in hepatitis C-infected patients

Journal of Interferon and Cytokine Research

Volumn 29, Issue 5, 2009, Pages 299-306

  Pfeffer, Lawrence M ^a   Madey, Margaret A ^a   Riely, Caroline A ^a   Fleckenstein, Jaquelyn F ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOLOGICAL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SERUM; SEX RATIO; TREATMENT RESPONSE;

ADULT; AGED; ANTIBODIES; FEMALE; HEPATITIS C; HUMANS; INTERFERON TYPE I; MALE; MIDDLE AGED;

HEPATITIS C VIRUS;

EID: 66749118387     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0092     Document Type: Article

References (28)

1. Bigger CB, Brasky KM, Lanford RE. 2001. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75(15):7059-7066.
2. Bigger CB, Guerra B, Brasky KM, Hubbard G, Beard MR, Luxon BA, Lemon SM, Lanford RE. 2004. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 78(24):13779-13792.
3. Castellino S, Lensing S, Riely C, Rai SN, Davila R, Hayden RT, Fleckenstein J, Levstik M, Taylor S, Dean PJ, Kippenbrock S, Pope J, Carr J, Strickland DK, Hudson MM. 2004. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 103(7):2460-2466.
4. Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, Heathcote J, Edwards AM, McGilvray ID. 2005. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128(5):1437-1444.
5. Darnell JEJ, Kerr IM, Stark GR. 1994. Jak-STAT pathways and tran-scriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
6. Du Z, Wei L, Murti A, Pfeffer SR, Fan M, Yang CH, Pfeffer LM. 2007. Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway. J Cell Biochem 102(5):1087-1094.
7. Fleckenstein J. 2004. Chronic hepatitis C in African Americans and other minority groups. Curr Gastroenterol Rep 6(1):66-70.
8. Foy E, Li K, Wang C, Sumpter R Jr., Ikeda M, Lemon SM, Gale M, Jr. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300(5622):1145-1148.
9. Gale M, Jr., Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436(7053):939-945.
10. He XS, Ji X, Hale MB, Cheung R, Ahmed A, Guo Y, Nolan GP, Pfeffer LM, Wright TL, Risch N and others. 2006. Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology 44(2):352-359.
11. Hiscott J, Lin R. 2006. Inhibition of the interferon antiviral response by hepatitis C virus. Expert Rev Clin Immunol 2:49-58.
12. Improta T, Pine R, Pfeffer LM. 1992. Interferon-g potentiates the antiviral activity and the expression of interferon-stimulated genes induced by interferon-a in U-937 cells. J Interferon Res 12:87-94.
13. Kessler DS, Pine R, Pfeffer LM, Levy DE, Darnell JEJ. 1988. Cells resistant to interferon are defective in activation of a promoter-binding factor. EMBO J 7:3779-3783.
14. Meylan E, Tschopp J, Karin M. 2006. Intracellular pattern recognition receptors in the host response. Nature 442(7098):39-44.
15. Mihm S, Frese M, Meier V, Wietzke-Braun P, Scharf JG, Bartenschlager R, Ramadori G. 2004. Interferon type I gene expressionin chronic hepatitis C. Lab Invest 84(9):1148-1159.
16. Muir AJ, Bornstein JD, Killenberg PG. 2004. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med 350(22):2265-2271.
17. Nanus DM, Pfeffer LM, Bander NH, Bahri S, Albino AP. 1990. Anti-proliferative and antitumor effects of alpha interferon in renal cell carcinomas: correlation with the expression of a kidney associated differentiation antigen. Cancer Res50:4190-4194.
18. Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S. 1998. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res 58(12):2489-2499.
19. Pfeffer LM, Tamm I. 1983. Comparison of the effects of alpha and beta interferons on the proliferation and volume of human tumor cells (HeLa-S3, Daudi, P3HR-1). J Interferon Res 3:395-408.
20. Rehermann B, Nascimbeni M. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5(3):215-229.
21. Reyes GR. 2001. Ribavirin: recent insights into antiviral mechanisms of action. Curr Opin Drug Discov Devel 4(5):651-656.
22. Rosenberg S. 2001. Recent advances in the molecular biology of hepatitis C virus. J Mol Biol 313(3):451-464.
23. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, Filipowicz W, Heim MH. 2008. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci USA 105(19):7034-7039.
24. Strader DB, Wright T, Thomas DL, Seeff LB. 2004. Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-1171.
25. Sumpter R Jr., Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79(5):2689-2699.
26. Taylor MW, Tsukahara T, Brodsky L, Schaley J, Sanda C, Stephens MJ, McClintick JN, Edenberg HJ, Li L, Tavis JE, Howell C, Belle SH. 2007. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J Virol 81(7):3391-3401.
27. Thimme R, Lohmann V, Weber F. 2006. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. Antiviral Res 69(3):129-141.
28. Wieland SF, Chisari FV. 2005. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79(15):9369-9380.